| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M A Ware, D Ziemiansk. Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25728558. |
medical education on cannabis and cannabinoids: perspectives, challenges, and opportunities. |
2015-08-12 |
2023-08-13 |
human |
| M A Ware, D Ziemiansk. Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25728558. |
the global regulatory landscape regarding the medical use of cannabis and cannabinoids is changing rapidly. |
2015-08-12 |
2023-08-13 |
human |
| D Bolognini, R A Ros. Medical cannabis vs. synthetic cannabinoids: What does the future hold? Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25761845. |
medical cannabis vs. synthetic cannabinoids: what does the future hold? |
2015-08-12 |
2023-08-13 |
Not clear |
| D I Abrams, M Guzma. Cannabis in cancer care. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25777363. |
cannabinoids, the active components of cannabis sativa, mimic the effects of the endogenous cannabinoids (endocannabinoids), activating specific cannabinoid receptors, particularly cb1 found predominantly in the central nervous system and cb2 found predominantly in cells involved with immune function. |
2015-08-12 |
2023-08-13 |
Not clear |
| D J Allsop, N Lintzeris, J Copeland, A Dunlop, I S McGrego. Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25777582. |
cannabinoid replacement therapy (crt): nabiximols (sativex) as a novel treatment for cannabis withdrawal. |
2015-08-12 |
2023-08-13 |
Not clear |
| M K Su, K A Seely, J H Moran, R S Hoffma. Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25788107. |
although the putative pharmacological targets of synthetic cannabinoids (scbs) abused in "k2" and "spice" are similar to Δ(9) -tetrahydrocannabinol (Δ(9) -thc), it remains unclear why scb toxicity is similar yet different from marijuana. |
2015-08-12 |
2023-08-13 |
Not clear |
| Aia Ahmed, M A van der Marck, Gah van den Elsen, Mgm Olde Rikker. Cannabinoids in late-onset Alzheimer's disease. Clinical pharmacology and therapeutics. vol 97. issue 6. 2015-08-12. PMID:25788394. |
the past few years have seen a growing interest in the medicinal uses of cannabinoids, the bioactive components of the cannabis plant, including the treatment of load and other physical conditions that are common in older people. |
2015-08-12 |
2023-08-13 |
Not clear |
| Ivonne Marie Figueroa-Rivera, Rodolfo Estremera-Marcial, Marielly Sierra-Mercado, José Gutiérrez-Núñez, Doris H Tor. Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect. Case reports in gastrointestinal medicine. vol 2015. 2015-08-12. PMID:26266060. |
cannabinoid hyperemesis syndrome: a paradoxical cannabis effect. |
2015-08-12 |
2023-08-13 |
Not clear |
| Ivonne Marie Figueroa-Rivera, Rodolfo Estremera-Marcial, Marielly Sierra-Mercado, José Gutiérrez-Núñez, Doris H Tor. Cannabinoid Hyperemesis Syndrome: A Paradoxical Cannabis Effect. Case reports in gastrointestinal medicine. vol 2015. 2015-08-12. PMID:26266060. |
despite well-established antiemetic properties of marijuana, there has been increasing evidence of a paradoxical effect in the gastrointestinal tract and central nervous system, given rise to a new and underrecognized clinical entity called the cannabinoid hyperemesis syndrome. |
2015-08-12 |
2023-08-13 |
Not clear |
| Rebecca L Hartman, Timothy L Brown, Gary Milavetz, Andrew Spurgin, David A Gorelick, Gary Gaffney, Marilyn A Huesti. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clinical chemistry. vol 61. issue 6. 2015-08-07. PMID:26019183. |
controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol. |
2015-08-07 |
2023-08-13 |
Not clear |
| Veronica I Alaniz, Jill Liss, Torri D Metz, Elaine Stickrat. Cannabinoid hyperemesis syndrome: a cause of refractory nausea and vomiting in pregnancy. Obstetrics and gynecology. vol 125. issue 6. 2015-08-04. PMID:25774930. |
cannabinoid hyperemesis syndrome is a condition present among chronic cannabis users resulting in abdominal pain, intractable nausea and vomiting, and compulsive bathing behaviors. |
2015-08-04 |
2023-08-13 |
Not clear |
| Neeraj Soni, Shankha Satpathy, Kristi A Kohlmeie. Neurophysiological evidence for the presence of cannabinoid CB1 receptors in the laterodorsal tegmental nucleus. The European journal of neuroscience. vol 40. issue 11. 2015-07-31. PMID:25251035. |
marijuana, which acts within the endocannabinoid (ecb) system as an agonist of the cannabinoid type 1 receptor (cb1r), exhibits addictive properties and has powerful actions on the state of arousal of an organism. |
2015-07-31 |
2023-08-13 |
mouse |
| Mark Personne, Jenny Westerbergh, Louise Hammer-Petterse. ["Spice"--synthetic cannabinoids with dangerous effects]. Lakartidningen. vol 111. issue 47. 2015-07-30. PMID:25386644. |
synthetic cannabinoids are a large group of chemicals functionally related to delta-9-tetrahydrocannabinol (thc) found in cannabis sativa. |
2015-07-30 |
2023-08-13 |
Not clear |
| Angela M Amedee, Whitney A Nichols, Nicole J LeCapitaine, Curtis Vande Stouwe, Leslie L Birke, Nedra Lacour, Peter J Winsauer, Patricia E Molin. Chronic Δ⁹-tetrahydrocannabinol administration may not attenuate simian immunodeficiency virus disease progression in female rhesus macaques. AIDS research and human retroviruses. vol 30. issue 12. 2015-07-24. PMID:25113915. |
persons living with hiv/aids (plwha) frequently use cannabinoids, either recreationally by smoking marijuana or therapeutically (delta-9-tetrahydrocannabinol; Δ(9)-thc dronabinol). |
2015-07-24 |
2023-08-13 |
Not clear |
| Pilar Sánchez-Blázquez, María Rodríguez-Muñoz, Raquel Herrero-Labrador, Javier Burgueño, Daniel Zamanillo, Javier Garzó. The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. The international journal of neuropsychopharmacology. vol 17. issue 12. 2015-07-21. PMID:24485144. |
in this framework, the recently reported association of cb1s with nmdars, which mediates the reduction of cannabinoid analgesia promoted by nmdar antagonism, could also support the precipitation of schizophrenia brought about by the abuse of smoked cannabis, mostly among vulnerable individuals. |
2015-07-21 |
2023-08-12 |
mouse |
| Andreja Celofiga, Jure Koprivsek, Janez Klav. Use of synthetic cannabinoids in patients with psychotic disorders: case series. Journal of dual diagnosis. vol 10. issue 3. 2015-07-17. PMID:25392292. |
synthetic cannabinoids are functionally similar to, but structurally different from, delta-9-tetrahydrocannabinol, the active principle in cannabis, and are problematic for many reasons. |
2015-07-17 |
2023-08-13 |
Not clear |
| Lynn Heis. Cannabinoid hyperemesis syndrome. Advanced emergency nursing journal. vol 37. issue 2. 2015-07-08. PMID:25929220. |
the best treatment of cannabinoid hyperemesis syndrome was found to be abstinence from the recreational use of marijuana. |
2015-07-08 |
2023-08-13 |
Not clear |
| Patrick D Skosnik, Giri P Krishnan, Deepak C D'Souza, William P Hetrick, Brian F O'Donnel. Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 39. issue 13. 2015-07-07. PMID:24990428. |
these data suggest that cannabis use may interfere with the generation of induced gamma-band neural oscillations that could in part mediate the perceptual-altering effects of exogenous cannabinoids. |
2015-07-07 |
2023-08-13 |
human |
| Fabio Arturo Iannotti, Charlotte L Hill, Antonio Leo, Ahlam Alhusaini, Camille Soubrane, Enrico Mazzarella, Emilio Russo, Benjamin J Whalley, Vincenzo Di Marzo, Gary J Stephen. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS chemical neuroscience. vol 5. issue 11. 2015-07-02. PMID:25029033. |
nonpsychotropic plant cannabinoids, cannabidivarin (cbdv) and cannabidiol (cbd), activate and desensitize transient receptor potential vanilloid 1 (trpv1) channels in vitro: potential for the treatment of neuronal hyperexcitability. |
2015-07-02 |
2023-08-13 |
rat |
| Fabio Arturo Iannotti, Charlotte L Hill, Antonio Leo, Ahlam Alhusaini, Camille Soubrane, Enrico Mazzarella, Emilio Russo, Benjamin J Whalley, Vincenzo Di Marzo, Gary J Stephen. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS chemical neuroscience. vol 5. issue 11. 2015-07-02. PMID:25029033. |
since the two nonpsychotropic cannabinoids cannabidivarin (cbdv) and cannabidiol (cbd) exert anticonvulsant activity in vivo and produce trpv1-mediated intracellular calcium elevation in vitro, we evaluated the effects of these two compounds on trpv1 channel activation and desensitization and in an in vitro model of epileptiform activity. |
2015-07-02 |
2023-08-13 |
rat |